a lonely feeling
is all around this webpage
can't find one like it
If you are certain you have the correct web address but are encountering an error, please contact the Site Administration. Thank you.
You are seeing this haiku because the page you were looking for cannot be found.
We apologize for the inconvenience, but the page you were trying to access is not at this address. You can use the links below to help you find what you are looking for.
You might have been looking for…
- 3C: A CAMPATH, Calcineurin inhibitor reduction and Chronic allograft nephropathy trial
- ELECTIVE CONVERSION TO SIROLIMUS VS. CONTINUED TACROLIMUS IN KIDNEY TRANSPLANTATION (THE 3C STUDY): RESULTS OF A RANDOMIZED TRIAL
-
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
Calcineurin inhibitors (CNIs, eg, tacrolimus) reduce short-term kidney transplant failure, but chronic nephrotoxicity may contribute to late transplant loss. ...
-
Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.
BACKGROUND: Kidney transplantation is the best treatment for patients with end-stage renal failure, but uncertainty remains about the best immunosuppression ...
-
Inferring causal genes at type 2 diabetes GWAS loci through chromosome interactions in islet cells.
Background: Resolving causal genes for type 2 diabetes at loci implicated by genome-wide association studies (GWAS) requires integrating functional genomic ...